CTRI/2022/05/042811CompletedPhase 4
A prospective, post market, non-interventional observational, open label, single arm, single center study to confirm the clinical safety and performance of Skanray’s Patient Monitors
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Skanray Technologies Limited
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •Adult, pediatric and neonatal subjects of either genders.
- •The patients who need continuous physiological parameters monitoring in different areas of the hospital (Ex; ICU, OT, emergency, wards, operative care etc.)
- •The subjects or the legally authorised representative capable of understanding and signing the informed consent.
Exclusion Criteria
- •Subjects who are to be monitored in an MRI environment or in an oxygen-enriched environment.
- •Neonates shall be excluded for ST segment and arrhythmia analysis.
Investigators
Similar Trials
Completed
Not Applicable
Post Market Clinical Follow Up Investigation of Intraskan DCCTRI/2020/12/029746Skanray Technologies Pvt Ltd
Completed
Phase 4
Post Market Clinical Follow Up Investigation of SKAN CCTRI/2020/12/029836Skanray Technologies Pvt Ltd
Completed
Phase 4
Post Market Clinical Follow Up of SkanRespiro Plus and PranaaCTRI/2022/05/042810Skanray Technologies Limited
Completed
Phase 4
Post Market Clinical Follow Up Investigation of Skanmobile and Skanmobile DRCTRI/2020/09/028059Skanray Technologies Pvt Ltd
Completed
Phase 4
Post Market Clinical Follow Up Investigation of microSKACTRI/2020/12/029799Skanray Technologies Pvt Ltd